Localization of PDE4D, HCN1 channels, and mGluR3 in rhesus macaque entorhinal cortex may confer vulnerability in Alzheimer's disease.

Alzheimer’s disease HCN1 PDE4D cAMP calbindin calcium entorhinal cortex immunoelectron microscopy mGluR3 macaque stellate cells

Journal

Cerebral cortex (New York, N.Y. : 1991)
ISSN: 1460-2199
Titre abrégé: Cereb Cortex
Pays: United States
ID NLM: 9110718

Informations de publication

Date de publication:
24 Oct 2023
Historique:
received: 01 05 2023
revised: 28 08 2023
accepted: 27 09 2023
medline: 24 10 2023
pubmed: 24 10 2023
entrez: 24 10 2023
Statut: aheadofprint

Résumé

Alzheimer's disease cortical tau pathology initiates in the layer II cell clusters of entorhinal cortex, but it is not known why these specific neurons are so vulnerable. Aging macaques exhibit the same qualitative pattern of tau pathology as humans, including initial pathology in layer II entorhinal cortex clusters, and thus can inform etiological factors driving selective vulnerability. Macaque data have already shown that susceptible neurons in dorsolateral prefrontal cortex express a "signature of flexibility" near glutamate synapses on spines, where cAMP-PKA magnification of calcium signaling opens nearby potassium and hyperpolarization-activated cyclic nucleotide-gated channels to dynamically alter synapse strength. This process is regulated by PDE4A/D, mGluR3, and calbindin, to prevent toxic calcium actions; regulatory actions that are lost with age/inflammation, leading to tau phosphorylation. The current study examined whether a similar "signature of flexibility" expresses in layer II entorhinal cortex, investigating the localization of PDE4D, mGluR3, and HCN1 channels. Results showed a similar pattern to dorsolateral prefrontal cortex, with PDE4D and mGluR3 positioned to regulate internal calcium release near glutamate synapses, and HCN1 channels concentrated on spines. As layer II entorhinal cortex stellate cells do not express calbindin, even when young, they may be particularly vulnerable to magnified calcium actions and ensuing tau pathology.

Identifiants

pubmed: 37874022
pii: 7328988
doi: 10.1093/cercor/bhad382
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIH HHS
ID : AG061190
Pays : United States

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Dibyadeep Datta (D)

Departments of Neuroscience, Yale University School of Medicine, New Haven, CT 06510, USA.
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06510, USA.

Isabella Perone (I)

Departments of Neuroscience, Yale University School of Medicine, New Haven, CT 06510, USA.

Yury M Morozov (YM)

Departments of Neuroscience, Yale University School of Medicine, New Haven, CT 06510, USA.

Jon Arellano (J)

Departments of Neuroscience, Yale University School of Medicine, New Haven, CT 06510, USA.

Alvaro Duque (A)

Departments of Neuroscience, Yale University School of Medicine, New Haven, CT 06510, USA.

Pasko Rakic (P)

Departments of Neuroscience, Yale University School of Medicine, New Haven, CT 06510, USA.

Christopher H van Dyck (CH)

Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06510, USA.

Amy F T Arnsten (AFT)

Departments of Neuroscience, Yale University School of Medicine, New Haven, CT 06510, USA.

Classifications MeSH